The U.S. Department of Health and Human Services (HHS) have set a goal to eliminate Hepatitis C as a public health threat by 2030.
Elimination of Hepatitis C in the U.S. would result in the significant reduction of the incidence of the infection - to the point where cases of the infection are rare and sporadic - as a result of deliberate efforts, with ongoing efforts to maintain the zero prevalence.
In 2017, HHS released its 2017-2020 Viral Hepatitis Action Plan to set the course for elimination of Hepatitis B and C in the U.S.
In 2016 and 2017. The National Academies of Sciences released a 2- part report on the Feasibility of Eliminating Hepatitis B and C in the U.S.
The availability of curative HCV drug treatments could make Hepatitis C elimination a reality, but only if those infected know their status, get treatment, and complete the course of therapy.
Elimination of Hepatitis C is feasible, but critical barriers must first be addressed:
1) *Poor Surveillance for HCV
2) Too few people know their status/inadequate screening
3) High Cost of HCV treatment drugs
4) Stigma associated with HCV infection
5) Public opinion that does not deem HCV as a public health priority, due to misinformation and lack of awareness of the illness